Ref: PXL/H.O./ CIR-113 /2016-17 Date: 24.02.2017
Hyderabad
To
Dear Sir/Madam,
Subject: IDMA & Pharmexcil joint programme on “Risk Management in Indian Pharmaceutical Industry (by UL Eduneering, USA)” during 6-7th March 2017 at Radisson Blu, Hyderabad and 9-10th March 2017 at Hotel Courtyard by Mariott , Mumbai.
Members are kindly aware Pharmexcil signed a MoU with UL Eduneering, USA recently in the month of September 2016 with the objective of promoting quality management and regulatory affairs in pharmaceuticals.
Part of the MoU, Pharmexcil in association with UL Eduneering and IDMA is delighted to inform that a two day Summit on “Risk Management in Indian Pharmaceutical Industry” is being organised during 6-7th March 2017 at Radisson Blu, Hyderabad and 9-10th March 2017 at Hotel Courtyard by Mariott , Mumbai.
The objective of the summit is to facilitate industry understand use of Total Quality Management (TQM), effective implementation of ICH Q9 Quality Risk Management, strategies to reduce risk of non-compliance, QRM Principles and share best practices. The summit will witness the presence of experts from industry & academia to discuss and debate on very pertinent topics on risk management. Ms.Anne Early, Former Director of Pfizer Inc and Senior Consultant, UL and Mr.Brian Nadel, Ex- Investigator, Compliance Officer (CDER Compliance Office, US FDA) and Senior Consultant UL from USA have confirmed their participation.
We are confident that the content of the said Conference would bring forth technical insights on the subject and acquaint the participating companies with emerging tools, technologies and methodologies for effective implementation of risk management in their manufacturing practices.
For more details about the event/fee info and participation registration, please contact Ms. Swati Sharma UL Edunnering, at swati.sharma@ul.com
With regards,
Uday Bhaskar
Director General
Encl: Programme
Registration |
